What is the challenge?There are over 50 million people worldwide living with dementia and by 2030 this number is expected to reach 82 million. The ageing brain becomes vulnerable to decline and keeping independency in daily life can become a challenge for the elderly. People with Mild Cognitive Impairment (MCI), an intermediate condition between normal brain ageing and dementia, may develop dementia in the future. There is an urgent need for early risk assessment and intervention. Current practices with time-consuming patient investigations focus on late symptoms management due to a lack of diagnostic tools. This causes numerous implications in terms of familial, medical and care costs. With AI-Mind we aim to reduce the disease’s burden by developing novel, AI-based tools to support healthcare professionals in their diagnosis and offering timely interventions to patients.
European Artificial Intelligence Act and webinar series from DNV
European Artificial Intelligence Act and webinar series from DNV The European Union (EU) takes a
MEG Nord 2023: Advancing Nordic Research in magnetoencephalography (MEG)
MEG Nord 2023: Advancing Nordic Research in Magnetoencephalography (MEG) MEG Nord 2023, the annual conference
At the heart of AI-Mind is our research study, that
Takes place in Norway, Finland, Italy and Spain and will involve 1,000 participants.
Helps to develop and validate artificial intelligence (AI) based tools to predict who is likely to develop dementia.
Visit our local study pages to learn more
Norway, Oslo University Hospital
Dr. Ira Haraldsen
Italy, IRCCS San Raffaele Roma
Prof. Paolo Rossini
Italy, Università Cattolica del Sacro Cuore
Prof. Camillo Mara
Finland, Helsinki University Hospital
Prof. Hanna Renvall
Spain, Complutense University of Madrit
Prof. Fernando Maestú